Cloud Pharmaceuticals, a therapeutics company focused on cloud-based drug design and development, has appointed two C-level executives to its management team. Lyle Lohmeyer joins the company as its chief financial officer and Don Van Dyke has been appointed chief operating officer.
Lohmeyer has extensive experience as a financial executive with specific expertise in M&A, fundraising, debt control and administration, and operations management industries such as pharmaceutical services, clinical research, electronics, software and manufacturing. At Cloud Pharmaceuticals, Lohmeyer’s responsibilities include financial management, fundraising, and business development.
Previously, Lohmeyer held financial management positions with companies such as AAIPharma, Qualia Networks, Energy Conversion Systems Holdings, Abaco Mobile and NAVTEQ. He started his career with PricewaterhouseCoopers in Chicago.
Van Dyke has been appointed to the role of chief operating officer. He previously was a consultant to the company and its director of marketing and business development. In his new role, Van Dyke is focusing on the business operations of the company. In addition, he is overseeing the company’s marketing and business development efforts.
Van Dyke has held general management, business development, and sales and marketing positions throughout his career with companies such as American Hospital Supply, Eastman Kodak and Millipore. He has built organizations from the ground up, beginning at startup Bio Image in various executive roles and ultimately CEO. He has held VP-level roles at Molecular Mining and INCOGEN, and has advised more than a dozen startups and government agencies.